Teva Pharms Inc Drug Patent Portfolio

Teva Pharms Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Teva Pharms Inc News

US appeals court reinstates Teva's lawsuit against Eli Lilly regarding migraine medication.

17 Apr, 2026

US appellate court reinstates Teva's lawsuit against Eli Lilly regarding migraine medication.

17 Apr, 2026

Projection for the Generic Oncology Medications Market by 2031 - Developments and Trends

14 Apr, 2026

Forecast for the Generic Oncology Drug Market by 2031: Trends and Growth Insights - openPR.com

14 Apr, 2026

See More